Epigenetic Targeted Therapy for Diffuse Intrinsic Pontine Glioma

Por HASHIZUME, Rintaro
Publicado no Neurol Med Chir (Tokyo) (2017)

Patient-derived Tumor Models for Diffuse Intrinsic Pontine Gliomas

Por Hashizume, Rintaro, Gupta, Nalin
Publicado no Curr Neuropharmacol (2017)

Epigenetic modification in chromatin machinery and its deregulation in pediatric brain tumors: Insight into epigenetic therapies

Por Maury, Eleonore, Hashizume, Rintaro
Publicado no Epigenetics (2017)

LSD1 inhibition in pHGG: the key to unleashing immunotherapy?

Por Nicolaides, Theodore P, Hashizume, Rintaro
Publicado no Neuro Oncol (2020)

DDRE-15. THE COMBINATION THERAPY OF PARP INHIBITOR AND TMZ IN DIFFUSE MIDLINE GLIOMA HARBORING H3 K27M-MUTANT

Por Ohba, Shigeo, Hashizume, Rintaro, Hirose, Yuichi
Publicado no Neuro Oncol (2020)

CS-34 EVIDENCE FOR OLIGODENDROCYTE ORIGINS OF PEDIATRIC GLIOMA

Por Tein, An-Chi, Griveau, Amelie, Hashizume, Rintaro, Rowitch, David
Publicado em 2014

Mutations in chromatin machinery and pediatric high-grade glioma

Por Lulla, Rishi R., Saratsis, Amanda Muhs, Hashizume, Rintaro
Publicado no Sci Adv (2016)

EXTH-60. CONVECTION-ENHANCED DELIVERY OF EZH2 INHIBITOR FOR THE TREATMENT OF DIFFUSE INTRINSIC PONTINE GLIOMA

Por Sasaki, Takahiro, Katagi, Hiroaki, Goldman, Stewart, Hashizume, Rintaro
Publicado no Neuro Oncol (2019)

Systemic and Local Drug Delivery for Treating Diseases of the Central Nervous System in Rodent Models

Por Serwer, Laura, Hashizume, Rintaro, Ozawa, Tomoko, James, C. David
Publicado em 2010

Future Clinical Trials in DIPG: Bringing Epigenetics to the Clinic

Por Morales La Madrid, Andres, Hashizume, Rintaro, Kieran, Mark W.
Publicado no Front Oncol (2015)

Bioluminescence Imaging of an Immunocompetent Animal Model for Glioblastoma

Por Clark, Aaron J., Fakurnejad, Shayan, Ma, Quanhong, Hashizume, Rintaro
Publicado no J Vis Exp (2016)

DDEL-11. CONVECTION-ENHANCED DELIVERY OF EZH2 INHIBITOR FOR THE TREATMENT OF DIFFUSE INTRINSIC PONTINE GLIOMA

Por Sasaki, Takahiro, Katagi, Hiroaki, Goldman, Stewart, Becher, Oren, Hashizume, Rintaro
Publicado no Neuro Oncol (2020)

TB-28 IMMUNOSUPPRESSIVE IDO1 AND TDO ARE EXPRESSED IN PEDIATRIC CENTRAL NERVOUS SYSTEM TUMORS

Por Lauing, Kristen L., Lulla, Rishi R., Hashizume, Rintaro, Wainwright, Derek A.
Publicado no Neuro Oncol (2016)

Therapeutic Hypothesis Testing With Rodent Brain Tumor Models

Por Wainwright, Derek A., Horbinski, Craig M., Hashizume, Rintaro, James, C. David
Publicado no Neurotherapeutics (2017)

Convection-Enhanced Delivery of Enhancer of Zeste Homolog-2 (EZH2) Inhibitor for the Treatment of Diffuse Intrinsic Pontine Glioma

Por Sasaki, Takahiro, Katagi, Hiroaki, Goldman, Stewart, Becher, Oren J, Hashizume, Rintaro
Publicado no Neurosurgery (2020)

ET-03 Convection-enhanced delivery of EZH2 inhibitor for the treatment of diffuse midline glioma

Por Sasaki, Takahiro, Katagi, Hiroaki, Oren, Becker, Stewart, Goldman, Nakao, Naoyuki, Hashizume, Rintaro
Publicado no Neurooncol Adv (2020)

Identification of internalizing human single chain antibodies targeting brain tumor sphere cells

Por Zhu, Xiaodong, Bidlingmaier, Scott, Hashizume, Rintaro, James, C. David, Berger, Mitchel S., Liu, Bin
Publicado em 2010

DIPG-25. IN VITRO AND IN VIVO ANALYSIS OF TENASCIN-C EXPRESSION IN PEDIATRIC BRAINSTEM GLIOMA

Por Qi, Jin, Huang, Tina, Hashizume, Rintaro, Tomita, Tadanori, James, C. David, Saratsis, Amanda
Publicado no Neuro Oncol (2017)

DIPG-19. MESENCHYMAL STEM CELLS TARGET DIFFUSE INTRINSIC PONTINE GLIOMA IN MICE AFTER INTRANASAL DELIVERY

Por Chastkofsky, Michael, Procissi, Daniele, Yang, Cynthia, Goldman, Stewart, Lesniak, Maciej, Hashizume, Rintaro, Balyasnikova, Irina
Publicado no Neuro Oncol (2017)

DIPG-36. NOVEL THERAPEUTIC APPROACHES USING NANOLIPOSMAL SN-38 FOR THE TREATMENT OF HUMAN BRAINSTEM GLIOMA

Por He, Xingyao, Louis, Nundia, Hashizume, Rintaro, Zhang, Peng, Balyasnikova, Irina, Horbinski, Craig, Goldman, Stewart
Publicado no Neuro Oncol (2017)